Lyra Deferred Long Term Liab from 2010 to 2024
LYRA Stock | USD 0.37 0 0.54% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 986.4 K | Current Value 876.8 K | Quarterly Volatility 61.4 K |
Check Lyra TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lyra main balance sheet or income statement drivers, such as Net Interest Income of 4.3 M, Interest Income of 4.3 M or Depreciation And Amortization of 264.1 K, as well as many exotic indicators such as Price To Sales Ratio of 106, Dividend Yield of 0.0 or PTB Ratio of 2.77. Lyra financial statements analysis is a perfect complement when working with Lyra TherapeuticsInc Valuation or Volatility modules.
Lyra | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out the analysis of Lyra TherapeuticsInc Correlation against competitors. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Lyra Stock analysis
When running Lyra TherapeuticsInc's price analysis, check to measure Lyra TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyra TherapeuticsInc is operating at the current time. Most of Lyra TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Lyra TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyra TherapeuticsInc's price. Additionally, you may evaluate how the addition of Lyra TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Lyra TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyra TherapeuticsInc. If investors know Lyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyra TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 0.03 | Quarterly Revenue Growth 0.298 | Return On Assets (0.38) | Return On Equity (0.96) |
The market value of Lyra TherapeuticsInc is measured differently than its book value, which is the value of Lyra that is recorded on the company's balance sheet. Investors also form their own opinion of Lyra TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Lyra TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyra TherapeuticsInc's market value can be influenced by many factors that don't directly affect Lyra TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyra TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyra TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyra TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.